EDGC Obtains Patent for Chromosomal Abnormality Detection Method

[Asia Economy Reporter Oh Ju-yeon] EDGC announced on the 22nd that it has obtained a patent in Singapore related to a method for determining chromosomal abnormalities. The company stated, "Sequencing can be performed regardless of the next-generation sequencing platform, enabling the determination of abnormalities in both autosomes and sex chromosomes," and explained, "Unique reads are extracted from the sequenced sequence data to determine the fetal gender."